Evaluation of the Quality of Self-collected Blood Spot Specimens for Laboratory HIV Testing - An InvolveMENt Sub Study
NCT02043041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2015-06-25
Summary
We will invite a convenience sample of up to 45 enrolled subjects to participate in an optional, self-administered blood specimen collection procedure to determine optimal procedures for collection.
Conditions
Interventions
- OTHER
-
Number of DBS Spots
The number of DBS spots on the card constitutes the experimental condition.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Emory University
lead OTHER
Principal Investigators
-
AD McNaghten, PHD, MHSA · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- United States
Study Locations
More Related Trials
-
HIV-1 Resistance at Screening for HIV Prevention Studies
NCT01204814 ·Status: COMPLETED
-
Screening Protocol for HIV Vaccine Studies
NCT00031304 ·Status: COMPLETED
-
The Cleveland Cardiometabolic Cohort
NCT03059121 ·Status: COMPLETED
-
Acute HIV Infection Observational Study
NCT00296660 ·Status: COMPLETED
-
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009 ·Status: RECRUITING
-
Study of Women Who Have AIDS
NCT00001050 ·Status: TERMINATED
-
Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
NCT00394004 ·Status: COMPLETED
-
Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent
NCT00001717 ·Status: COMPLETED
-
Vitamin D Supplementation in HIV Youth
NCT01523496 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
NCT02258685 ·Status: COMPLETED
-
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
NCT00857350 ·Status: COMPLETED
-
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay
NCT00686205 ·Status: COMPLETED ·Phase: PHASE3
-
The DC Cohort Longitudinal HIV Status Neutral Study
NCT01206920 ·Status: RECRUITING
-
Use of a Test That Evaluates How the Body Handles Insulin and Glucose
NCT00027092 ·Status: COMPLETED
-
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442 ·Status: COMPLETED
-
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
NCT03337906 ·Status: COMPLETED
-
Evaluation of HIV-1 Recent Infection Testing in Rwanda
NCT05063487 ·Status: COMPLETED
-
Problems With Immune Recovery in the Gut Tissue
NCT01460433 ·Status: COMPLETED
-
Validation of Self-Reported Needle Sharing Among Injection Drug Users
NCT00341081 ·Status: COMPLETED
-
Impact of ART Adherence on HIV Persistence and Inflammation
NCT02797093 ·Status: COMPLETED
-
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
NCT00636220 ·Status: COMPLETED
-
Clinical Epidemiology Cohort Study for Patient Living With HIV
NCT04061889 ·Status: UNKNOWN
-
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
NCT01202305 ·Status: RECRUITING
-
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections
NCT00000858 ·Status: COMPLETED
-
The Detection of Drug-Resistant HIV-1 in Taiwan
NCT00690001 ·Status: UNKNOWN